Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Bilski blundering biotech

Is the Federal Circuit's decision in In re: Bilski yet a further restraint on patenting biotech and pharmaceutical inventions?

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Figure 1


  1. Anonymous. The Economic Times 3 February 2009 <>.

  2. Giovanetti, G.T. & Jaggi, G. Beyond Borders: Global Biotechnology Report 2008 (Ernst & Young, 2008).

    Google Scholar 

  3. Dernis, H. Compendium of Patent Statistics 2008 (Organisation for Economic Co-operation and Development, Paris, 2008) <>.

    Google Scholar 

  4. KSR International Co. v. Teleflex Inc., 550 US _____ (2007).

  5. Quanta v. LG Electronics, __ US __ (2008).

  6. In re: Seagate Technology, LLC, Misc. Dkt. No. 830 (Fed. Cir. Aug. 20, 2007).

  7. In re: Bilski, 545 F.3d 943 (Fed. Cir. 2008) (en banc).

  8. 35 USC §273.

  9. King Pharmaceuticals, Inc. et al. v. EON Labs, Inc., EDNY (1-04-cv-05540) (2009).

  10. Ariad Pharmaceuticals Inc. v. Eli Lilly & Co., Fed. Cir., No. 2008-1248.

  11. Dutra, T. BNA's Patent, Trademark & Copyright J. 25 (2009)

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and Permissions

About this article

Cite this article

Simmons, W. Bilski blundering biotech. Nat Biotechnol 27, 245–248 (2009).

Download citation

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing